Page last updated: 2024-08-16

pirinixic acid and lactacystin

pirinixic acid has been researched along with lactacystin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asp, L; Borén, J; Claesson, C; Gustafsson, M; Li, L; Lindberg, K; Lindén, D; Olofsson, SO; Oscarsson, J	1
Kankaanranta, H; Leppänen, T; Moilanen, E; Paukkeri, EL; Sareila, O; Vuolteenaho, K	1

Other Studies

2 other study(ies) available for pirinixic acid and lactacystin

Article	Year
Influence of peroxisome proliferator-activated receptor alpha agonists on the intracellular turnover and secretion of apolipoprotein (Apo) B-100 and ApoB-48. The Journal of biological chemistry, 2002, Jun-21, Volume: 277, Issue:25 Topics: Acetylcysteine; Animals; Apolipoprotein B-100; Apolipoprotein B-48; Apolipoproteins B; Cell Line; Cells, Cultured; Clofibrate; Cytosol; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Enzyme Inhibitors; Female; Immunoblotting; Oleic Acid; Palmitic Acid; Protein Binding; Protein Biosynthesis; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Time Factors; Transcription Factors; Transcription, Genetic; Transfection; Triglycerides; Tumor Cells, Cultured	2002
PPARalpha agonists inhibit nitric oxide production by enhancing iNOS degradation in LPS-treated macrophages. British journal of pharmacology, 2007, Volume: 152, Issue:7 Topics: Acetylcysteine; Animals; Butyrates; Cells, Cultured; Dose-Response Relationship, Drug; Leupeptins; Lipopolysaccharides; Macrophages; Mice; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Phenylurea Compounds; PPAR alpha; Proteasome Endopeptidase Complex; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; STAT1 Transcription Factor	2007

Article

Year

Influence of peroxisome proliferator-activated receptor alpha agonists on the intracellular turnover and secretion of apolipoprotein (Apo) B-100 and ApoB-48.

The Journal of biological chemistry, 2002, Jun-21, Volume: 277, Issue:25

Topics: Acetylcysteine; Animals; Apolipoprotein B-100; Apolipoprotein B-48; Apolipoproteins B; Cell Line; Cells, Cultured; Clofibrate; Cytosol; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Enzyme Inhibitors; Female; Immunoblotting; Oleic Acid; Palmitic Acid; Protein Binding; Protein Biosynthesis; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Time Factors; Transcription Factors; Transcription, Genetic; Transfection; Triglycerides; Tumor Cells, Cultured

2002

PPARalpha agonists inhibit nitric oxide production by enhancing iNOS degradation in LPS-treated macrophages.

British journal of pharmacology, 2007, Volume: 152, Issue:7

Topics: Acetylcysteine; Animals; Butyrates; Cells, Cultured; Dose-Response Relationship, Drug; Leupeptins; Lipopolysaccharides; Macrophages; Mice; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Phenylurea Compounds; PPAR alpha; Proteasome Endopeptidase Complex; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; STAT1 Transcription Factor

2007